Literature DB >> 9580776

Identification of a genetic cause for isolated unilateral coronal synostosis: a unique mutation in the fibroblast growth factor receptor 3.

K W Gripp1, D M McDonald-McGinn, K Gaudenz, L A Whitaker, S P Bartlett, P M Glat, L B Cassileth, R Mayro, E H Zackai, M Muenke.   

Abstract

To determine whether the autosomal dominant fibroblast growth factor receptor 3 (FGFR3) Pro250Arg mutation causes anterior plagiocephaly, patients with either apparently sporadic unicoronal synostosis (N = 37) or other forms of anterior plagiocephaly (N = 10) were studied for this mutation. Of 37 patients with unicoronal synostosis, 4 tested positive for the Pro250Arg mutation in FGFR3, and 33 were negative for this mutation. In three mutation positive patients with full parental studies, a parent with an extremely mild phenotype was found to carry the same mutation. None of the 6 patients with nonsynostotic plagiocephaly and none of the 4 patients with additional suture synostosis had the FGFR3 mutation. Because it is impossible to predict the FGFR3 Pro250Arg mutation status based on clinical examination alone, all patients with unicoronal synostosis should be tested for it. To assess their recurrence risk, all parents of mutation positive patients should be tested regardless of their clinical findings, because the phenotype can be extremely variable and without craniosynostosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580776     DOI: 10.1016/s0022-3476(98)70366-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

Review 1.  Neurodevelopmental implications of "deformational" plagiocephaly.

Authors:  Brent Collett; David Breiger; Darcy King; Michael Cunningham; Matthew Speltz
Journal:  J Dev Behav Pediatr       Date:  2005-10       Impact factor: 2.225

2.  Unilateral and bilateral expression of a quantitative trait: asymmetry and symmetry in coronal craniosynostosis.

Authors:  Yann Heuzé; Neus Martínez-Abadías; Jennifer M Stella; Craig W Senders; Simeon A Boyadjiev; Lun-Jou Lo; Joan T Richtsmeier
Journal:  J Exp Zool B Mol Dev Evol       Date:  2012-03       Impact factor: 2.656

Review 3.  Posterior plagiocephaly.

Authors:  Ricky Kalra; Marion L Walker
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

Review 4.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

5.  A young patient with polyarthralgia and hearing loss: a case report of Muenke syndrome.

Authors:  Manjiri M Didolkar; Emily N Vinson; Ana M Gaca
Journal:  Skeletal Radiol       Date:  2009-05-16       Impact factor: 2.199

6.  Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis.

Authors:  Sahan V Rannan-Eliya; Indira B Taylor; I Marieke De Heer; Ans M W Van Den Ouweland; Steven A Wall; Andrew O M Wilkie
Journal:  Hum Genet       Date:  2004-07-07       Impact factor: 4.132

7.  Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation.

Authors:  E Lajeunie; V El Ghouzzi; M Le Merrer; A Munnich; J Bonaventure; D Renier
Journal:  J Med Genet       Date:  1999-01       Impact factor: 6.318

8.  Muenke syndrome.

Authors:  G Sabatino; F Di Rocco; G Zampino; G Tamburrini; M Caldarelli; C Di Rocco
Journal:  Childs Nerv Syst       Date:  2004-02-10       Impact factor: 1.475

9.  The intracranial pressure of the patients with mild form of craniosynostosis.

Authors:  Takayuki Inagaki; Shigeo Kyutoku; Takatoshi Seno; Takuya Kawaguchi; Takashi Yamahara; Hideyuki Oshige; Yasuo Yamanouchi; Keiji Kawamoto
Journal:  Childs Nerv Syst       Date:  2007-08-07       Impact factor: 1.475

10.  Q289P mutation in the FGFR2 gene: first report in a patient with type 1 Pfeiffer syndrome.

Authors:  Maria Piccione; Vincenzo Antona; Marcello Niceta; Carmelo Fabiano; Manuela Martines; Alberto Bianchi; Giovanni Corsello
Journal:  Eur J Pediatr       Date:  2008-12-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.